ZBIO — Zenas BioPharma, Inc. stock price, charts and financials

QT61Zenas BioPharma, Inc.

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.42
+0.29+0.93%
OverviewShort InterestFilings
ZBIOQT61Zenas BioPharma, Inc.·NASDAQ
31.42+0.93%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 13, 20268-KCurrent report
May 13, 202610-QQuarterly report
May 05, 2026SC 13DBeneficial ownership statement (active)
Apr 29, 20264Statement of changes in beneficial ownership
Apr 02, 20264Statement of changes in beneficial ownership
Apr 02, 2026SC 13D/ABeneficial ownership statement (active, amended)
Apr 01, 20264Statement of changes in beneficial ownership
Mar 31, 20264Statement of changes in beneficial ownership
Mar 31, 20264Statement of changes in beneficial ownership
Mar 31, 20268-KCurrent report
Mar 30, 2026424B5Prospectus
Mar 30, 2026424B5Prospectus
Mar 27, 2026FWPFree writing prospectus
Mar 27, 2026FWPFree writing prospectus
#1 / 25 of 176
Page
▼
/ 8